For the majority of patients in clinical trials, tirzepatide resulted in greater weight loss and better blood sugar control due to its dual GIP and GLP 1 action
Neuroscience 164, 9981008.10.1016/j.neuroscience.2009.09.015 20 BlmlS.WisnowskiJ
Studies show that Semaglutide can lead to significant weight loss when combined with diet and exercise, offering women a practical way to manage their weight and feel more in control of their bodies during this transitional period. Metabolic Health Improvements: Supporting Blood Sugar and Heart Health In addition to weight gain, hormonal changes during menopause can affect blood sugar levels and increase the risk of metabolic syndromea collection of conditions, including high blood pressure, high blood sugar, and abnormal cholesterol levels, that increase the risk of heart disease, stroke, and diabetes. Semaglutides impact on blood sugar control can be particularly beneficial for menopausal women, as it helps stabilize blood glucose and reduces insulin resistance
Consequently, contemporary guidance has shifted toward individualized risk assessment rather than universal medication withholding
